Application of oncogenetic trees mixtures as a biostatistical model of the clonal cytogenetic evolution of meningiomas

No abstract is available for this paper.

• Publication year

  2007

• Venue

  International Journal of Cancer

• Publication date

  2007-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.22855PMID 17557299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Cytogenetic Relationship between Primary and Recurrent Meningiomas Points to the Need for New Treatment Strategies in Cases at High Risk of Relapse

  2006cited by this paper
• Estimating cancer survival and clinical outcome based on genetic tumor progression scores

  2005cited by this paper
• Mtreemix: a software package for learning and using mixture models of mutagenetic trees

  2005cited by this paper
• Triple approach for diagnosis and grading of meningiomas: Histology, morphometry of Ki-67/feulgen stainings, and cytogenetics

  2005cited by this paper
• Tumors of the meninges: proposed modifications of the World Health Organization classification

  2004cited by this paper
• Learning Multiple Evolutionary Pathways from Cross-Sectional Data

  2004influential reference
• Meningiomas.

  2004cited by this paper
• Molecular pathogenesis of meningiomas

  2004cited by this paper
• Histological subtypes and prognostic problems in meningiomas

  2004cited by this paper
• Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?

  2004cited by this paper
• Maximum likelihood estimation of oncogenetic tree models.

  2004cited by this paper
• New classification scheme for the prognostic stratification of meningioma on the basis of chromosome 14 abnormalities, patient age, and tumor histopathology.

  2003cited by this paper
• Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases

  2001cited by this paper
• Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases.

  2001cited by this paper
• Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data.

  2000cited by this paper
• Correlation of the relationships of brain-tumor interfaces, magnetic resonance imaging, and angiographic findings to predict cleavage of meningiomas.

  1999cited by this paper
• Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas.

  1999cited by this paper
• Inferring Tree Models for Oncogenesis from Comparative Genome Hybridization Data

  1999influential reference
• Predicting the probability of meningioma recurrence based on the quantity of peritumoral brain edema on computerized tomography scanning.

  1999cited by this paper
• Loss of Alkaline Phosphatase Activity in Meningiomas: A Rapid Histochemical Technique Indicating Progression‐associated Deletion of a Putative Tumor Suppressor Gene on the Distal Part of the Short Arm of Chromosome 1

  1997cited by this paper
• Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.

  1997cited by this paper
• Factors associated with survival in patients with meningioma.

  1997cited by this paper
• Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative `tumor progression' locus

  1997cited by this paper
• Prediction of recurrence in histologically benign meningiomas: proliferating cell nuclear antigen and Ki-67 immunohistochemical study.

  1997cited by this paper
• Characterization of intermediate type (WHO "atypical") meningiomas.

  1996cited by this paper
• Correlation between cytogenetic and clinical findings in 215 human meningiomas.

  1996cited by this paper
• Cytogenetic analysis of aggressive meningiomas: Possible diagnostic and prognostic implications

  1995cited by this paper
• Monosomy 1p is correlated with enhanced in vivo glucose metabolism in meningiomas.

  1995cited by this paper
• Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression.

  1995cited by this paper
• Allelic loss at 1 p is associated with tumor progression of meningiomas

  1994cited by this paper
• Atypical and malignant meningiomas: a clinicopathological review.

  1993cited by this paper
• Atypical and malignant meningiomas: importance of micronecrosis as a prognostic indicator

  1993cited by this paper
• Atypical and malignant meningiomas: a clinicopathological review.

  1993cited by this paper
• Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors.

  1986cited by this paper
• Meningioma: analysis of recurrence and progression following neurosurgical resection.

  1985cited by this paper
• Morbidity, mortality, and quality of life following surgery for intracranial meningiomas. A retrospective study in 257 cases.

  1984cited by this paper
• The recurrence of intracranial meningiomas after surgical treatment.

  1983cited by this paper
• Cytological and cytogenetical studies on human meningioma.

  1982cited by this paper
• Correlations between clinical and cytogenetical data in 180 human meningiomas

  1980influential reference
• Regression models and life tables (with discussion

  1972cited by this paper
• Chromosomal Constitution of Meningiomas

  1967cited by this paper
• Chromosomal consitution of meningiomas.

  1967cited by this paper
• THE CRANIAL HYPEROSTOSES PRODUCED BY MENINGEAL ENDOTHELIOMAS

  1922cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Posterior parasagittal meningiomas display aggressive features independent of size: a multicenter analysis

  2025cites this paper
• Spatially Encoded Oncogenesis and Transcriptional Plasticity in Meningioma: Drivers of Therapeutic Resistance and Opportunities for Targeted Intervention

  2025cites this paper
• AlkaPhos: a novel fluorescent probe as a potential point-of-care diagnostic tool to estimate recurrence risk of meningiomas

  2025cites this paper
• Merlin immunohistochemistry is a reliable surrogate marker for NF2 gene alterations in meningioma

  2025cites this paper
• The Evolving Classification of Meningiomas: Integration of Molecular Discoveries to Inform Patient Care

  2024cites this paper
• Risk factors on surgical compliance and its impact on survival outcomes in meningioma patients: a SEER-based retrospective propensity-score matched analysis

  2024cites this paper
• Noncoding RNA landscape and their emerging roles as biomarkers and therapeutic targets in meningioma

  2024cites this paper
• European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection

  2024cites this paper
• cIMPACT-NOW Update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas.

  2024cites this paper
• Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients

  2024cites this paper
• Prognostic Factors Affecting Postsurgical Outcomes of Adult Patients with Intracranial Meningioma: A Retrospective Study.

  2023cites this paper
• A typology of cerebral small vessel disease based on imaging markers

  2023cites this paper
• Integration of molecular pathology with histopathology to accurately evaluate the biological behaviour of WHO grade 2 meningiomas and patient prognosis

  2022cites this paper
• MicroRNA 200a as a histologically independent marker for meningioma recurrence: Results of a four microRNA panel analysis in meningiomas

  2022cites this paper
• Incidence and survival of benign, borderline, and malignant meningioma patients in the United States from 2004 to 2018

  2022cites this paper
• Fluorescence image-guided resection of intracranial meningioma: an experimental in vivo study on nude mice.

  2021cites this paper
• Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated

  2021cites this paper
• Incidence, survival and geoepidemiological analysis of Meningiomas and Glioblastomas in the province of Catania during the 2003-2016 period.

  2021cites this paper
• Rapid Intraoperative Diagnosis of Meningiomas using Stimulated Raman Histology.

  2021cites this paper
• Meningiomas: An Overview of the Landscape of Copy Number Alterations in Samples from an Admixed Population

  2020cites this paper
• Total DNA methylation as a biomarker of DNA damage and tumor malignancy in intracranial meningiomas

  2020cites this paper
• The Loss of 1p as a Reliable Marker of Progression in a Child with Aggressive Meningioma: A 16-Year Follow-Up Case Report

  2020cites this paper
• Neurofibromatosis type 2: A nationwide population-based study focused on survival after meningioma surgery.

  2020cites this paper
• Scalp invasion by atypical or anaplastic meningioma is a risk factor for development of systemic metastasis.

  2020cites this paper
• Deletions in the 17q chromosomal region and their influence on the clonal cytogenetic evolution of recurrent meningiomas

  2019cites this paper
• Fluorescence imaging of meningioma cells with somatostatin receptor ligands: an in vitro study

  2019cites this paper
• Incidence, mortality and outcome of meningiomas: A population-based study from Germany.

  2019cites this paper
• Advances in meningioma genetics: novel therapeutic opportunities

  2018cites this paper
• Clinical impact of MYC abnormalities in plasma cell myeloma.

  2018cites this paper
• The correlation of clinical and chromosomal alterations of benign meningiomas and their recurrences.

  2016cites this paper
• Prognosis of meningiomas in the early 1970s and today.

  2016cites this paper
• Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade

  2016cites this paper
• Genetic/molecular alterations of meningiomas and the signaling pathways targeted

  2015cites this paper
• Patterns of protein expression and cytogenetic alterations in meningiomas: relationship with the clinical and biological features of the disease

  2015influential citation
• Expressions of Aquaporin4, VEGFR1 and the pattern of genetic aberrations in meningiomas have no influence on the peritumoral edema

  2015cites this paper
• Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype.

  2014cites this paper
• Molecular Biological Determinations of Meningioma Progression and Recurrence

  2014cites this paper
• Establishment of a molecular cytogenetic analysis for native tumor tissue of meningiomas-suitable for clinical application

  2014cites this paper
• Recurrence and Progression in Meningiomas: The Clonal Cytogenetic Evolution of a Benign Human Tumour

  2013cites this paper
• Tumor Phylogenetics in the NGS Era: Strategies, Challenges, and Future Prospects

  2013cites this paper
• Inferring tumor evolution using computational phylogenetics

  2013cites this paper
• SAMPLE SIZE ESTIMATION FOR CANCER PROGRESSION MODELS

  2012cites this paper
• Delineation of commonly deleted chromosomal regions in meningiomas by high‐density single nucleotide polymorphism genotyping arrays

  2012cites this paper
• Recurrence and Progression in Meningiomas

  2012cites this paper
• Clonal cytogenetic progression within intratumorally heterogeneous meningiomas predicts tumor recurrence.

  2011cites this paper
• 22 – Meningeal Tumors

  2010cites this paper
• Fluorescent in situ hybridization 1p/19q deletion/imbalance analysis of low-grade and atypical meningiomas.

  2010cites this paper
• Correspondence of Tumor Localization with Tumor Recurrence and Cytogenetic Progression in Meningiomas.

  2009cites this paper
• Construction of oncogenetic tree models reveals multiple pathways of oral cancer progression

  2009cites this paper
• Anaplastic meningioma: Progression from atypical and chordoid morphotype with morphologic spectral variation at recurrence

  2009cites this paper
• Gene Expression Profiles of Meningiomas are Associated with Tumor Cytogenetics and Patient Outcome

  2009cites this paper
• Advances in meningioma therapy

  2009cites this paper
• ESTIMATING EVOLUTIONARY PATHWAYS AND GENETIC PROGRESSION SCORES WITH RTREEMIX

  2008cites this paper
• Rtreemix: an R package for estimating evolutionary pathways and genetic progression scores

  2008cites this paper
• Meningeome

  2008cites this paper
• CORRESPONDENCE OF TUMOR LOCALIZATION WITH TUMOR RECURRENCE AND CYTOGENETIC PROGRESSION IN MENINGIOMAS

  2008influential citation